5-Chloro-1H-pyrrolo[2,3-b]pyridine-4-carboxylic acid, 98+%, 1g

2,2,2-Trifluoro-1-(pyridin-2-yl)ethanone, 95.0%, 5g

(R)-3-(3-Fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one, 95.0%, 250mg

8-Bromo-quinoline, 97.00%, 1g

2-(4-(Methoxymethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

2,4-DICHLORO-7-METHOXY-8-METHYL-QUINOLINE, 97.0%, 1g

Potassium ICP Standard Solution, 500mL, 10,000mg/L K, HDPE

Ethyl 1,3-dimethyl-1H-pyrazole-4-carboxylate, 95.0%, 250mg

N,N-Dicyclohexylcarbodiimide (DCC), 1 kg, >=98%, glass packaging

3-(1-Butyl-pentyl)-pyridine, 1g

2-(2,4-Difluorophenyl)-2,2-difluoroethan-1-amine hydrochloride, 95.0%, 250mg

N-(4-Bromopyridin-2-yl)acetamide, 95.0%, 25g

N-Benzyl-2-chloro-N-ethylacetamide, 95+%, 1g